Valuation Verastem, Inc.

Stocks

Market Closed - Nasdaq 23:00:00 15/09/2026 +03			5-day change	1st Jan Change
7.340 ^USD	-2.26%		-10.49%	-4.92%

09-14	RTW Biotech NAV rises 15% as public investments drive returns	AN
09-08	Verastem Oncology Unveils New Clinical Data Highlighting The Best-In-Class Potential Of VS-7375, An Oral KRAS G12D (ON/OFF) Inhibitor Across Pancreatic, Lung, And Colorectal Cancers	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	373.5	84.56	205.7	230.1	595.8	680.1	-	-
Change	-	-77.36%	143.23%	11.87%	158.95%	14.15%	-	-
Enterprise Value (EV) ¹	373.5	84.56	205.7	230.1	595.8	722	680.1	680.1
Change	-	-77.36%	143.23%	11.87%	158.95%	21.18%	-5.8%	0%
P/E	-5x	-1.06x	-2.06x	-1.41x	-2.56x	-4.68x	-6.45x	-9.53x
PBR	-	-	-	-	-	-	-	-
PEG	-	0.14x	0.2x	0.19x	0.1x	0.1x	0.2x	0.3x
Capitalization / Revenue	182x	32.6x	-	23x	19.3x	5.84x	3.75x	2.59x
EV / Revenue	182x	32.6x	-	23x	19.3x	6.2x	3.75x	2.59x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-6.08x	-1.16x	-2.23x	-2x	-3.5x	-4.16x	-4.36x	-5.98x
EV / FCF	-	-	-2.38x	-2.2x	-4.05x	-4.35x	-4.54x	-7.02x
FCF Yield	-	-	-42%	-45.5%	-24.7%	-23%	-22%	-14.2%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-4.92	-4.56	-3.96	-3.66	-3.02	-1.603	-1.165	-0.7883
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	2.053	2.596	-	10	30.91	116.4	181.1	262.1
EBITDA	-	-	-	-114.9	-	-	-	-
EBIT ¹	-61.41	-72.94	-92.08	-115	-170.1	-173.4	-155.9	-113.7
Net income ¹	-71.2	-73.81	-87.37	-130.6	-209.5	-165.9	-157.1	-112.4
Net Debt ¹	-	-	-	-	-	41.9	-	-
Reference price ²	24.600	4.830	8.140	5.170	7.720	7.510	7.510	7.510
Nbr of stocks (in thousands)	15,182	17,508	25,268	44,507	77,182	90,563	-	-
Announcement Date	3/28/22 A	3/14/23 A	3/14/24 A	3/20/25 A	3/4/26 A	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
VERASTEM, INC.	-4.68x	6.2x	-	-	680M
WUXI APPTEC CO., LTD.	20.63x	7.28x	14.62x	1.44%	70.24B
ARGENX SE	32.28x	9.34x	45.05x	0.04%	62.63B
INSMED INCORPORATED	-76.7x	14.8x	-71.37x	-.--%	27.36B
WUXI BIOLOGICS (CAYMAN) INC.	29.77x	6.32x	16.41x	-.--%	25.71B
BIONTECH SE	-15.03x	5.62x	-7.06x	-.--%	24.83B
GENMAB A/S	26.45x	5.03x	16.73x	-.--%	19.52B
PHARMAESSENTIA CORPORATION	44.88x	16.47x	33.42x	0.34%	15.51B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1267.62x	36.68x	797.93x	-.--%	14.66B
SUMMIT THERAPEUTICS INC.	-15.8x	3569.89x	-18.25x	-.--%	14.69B
Average	130.94x	367.76x	91.94x	0.2%	27.58B
Weighted average by Cap.	77.33x	199.96x	52.40x	0.4%